Trial Outcomes & Findings for Comparison of Carotenoid Bioavailability From Fresh Papaya, Tomato and Carrot (NCT NCT01748916)
NCT ID: NCT01748916
Last Updated: 2025-10-20
Results Overview
The primary goal of this research is to investigate whether papaya can deliver increased quantities of carotenoids when compared to carrot and tomato. An area under the curve for concentration of carotenoids (from triglyceride rich lipoprotein (TRL) fraction of plasma) over time will be determined to quantify absorption, after subjects consume a meal containing papaya, carrot or tomato.
COMPLETED
NA
16 participants
8 post-prandial blood samples over 9.5 hours
2025-10-20
Participant Flow
Recruitment was carried out at the University of Costa Rica during June 2011 - August 2011.
Sixteen healthy, non-pregnant, non-smoking participants (21-44 y) were enrolled after checking eligibility, which was based on a questionnaire. Exclusion criteria included any history of chronic gastrointestinal disease, use of medications affecting lipid metabolism, regular use of carotenoid-containing supplements and frequent alcohol consumption.
Participant milestones
| Measure |
Papaya-Carrot-Tomato
Test meals were consumed in the following order: 1. Papaya 2. Carrot 3. Tomato.
Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
|
Papaya-Tomato-Carrot
Test meals were consumed in the following order: 1. Papaya 2. Tomato 3. Carrot
Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
|
Tomato-Papaya-Carrot
Test meals were consumed in the following order: 1. Tomato 2. Papaya 3. Carrot
Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
|
Tomato-Carrot-Papaya
Test meals were consumed in the following order: 1. Tomato 2. Carrot 3. Papaya
Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
|
Carrot-Papaya-Tomato
Test meals were consumed in the following order: 1. Carrot 2. Papaya 3. Tomato
Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
|
Carrot-Tomato-Papaya
Test meals were consumed in the following order: 1. Carrot 2. Tomato 3. Papaya
Papaya: Post-prandial study feeding 400-506 g papaya (1.6 mg beta-carotene, 2.1 mg beta-cryptoxanthin, 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Carrot: Post-prandial study feeding 25-35 g carrot (= 1.6 mg beta-carotene), 150 g yogurt (10% fat), and 45 g of fat free bread.
Tomato: Post-prandial study feeding 256-396 g tomato (= 13 mg lycopene), 150 g yogurt (10% fat), and 45 g of fat free bread.
|
|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
2
|
3
|
2
|
3
|
3
|
3
|
|
Overall Study
COMPLETED
|
2
|
3
|
2
|
3
|
3
|
3
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Comparison of Carotenoid Bioavailability From Fresh Papaya, Tomato and Carrot
Baseline characteristics by cohort
| Measure |
All Groups (Average)
n=16 Participants
All study participants
|
|---|---|
|
Age, Continuous
|
27 years
n=5 Participants
|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
16 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=5 Participants
|
|
Region of Enrollment
Costa Rica
|
16 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 8 post-prandial blood samples over 9.5 hoursThe primary goal of this research is to investigate whether papaya can deliver increased quantities of carotenoids when compared to carrot and tomato. An area under the curve for concentration of carotenoids (from triglyceride rich lipoprotein (TRL) fraction of plasma) over time will be determined to quantify absorption, after subjects consume a meal containing papaya, carrot or tomato.
Outcome measures
| Measure |
Beta-Carotene Absorption From Papaya
n=16 Participants
|
Beta-Carotene Absorption From Tomato
n=16 Participants
|
Beta-Carotene Absorption From Carrot
n=16 Participants
|
Lycopene Absorption From Papaya
n=16 Participants
|
Lycopene Absorption From Tomato
n=16 Participants
|
|---|---|---|---|---|---|
|
Pharmacokinetics of Carotenoid Absorption From Papaya, Carrot and Tomato
|
163 nmol*h/L
Interval 155.0 to 210.0
|
62 nmol*h/L
Interval 28.0 to 103.0
|
64 nmol*h/L
Interval 40.0 to 96.0
|
174 nmol*h/L
Interval 130.0 to 249.0
|
58 nmol*h/L
Interval 47.0 to 102.0
|
Adverse Events
All Groups
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place